Chargement en cours...
Atezolizumab-induced type 1 diabetes mellitus in a patient with metastatic renal cell carcinoma
Checkpoint inhibitor immunotherapy has revolutionised cancer treatment since its inception. During an inflammatory response, activated cytotoxic T cells expressing programmed cell death protein 1 (PD-1) interact with programmed cell death-ligand 1 (PD-L1) on peripheral tissues to thwart an autoimmun...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333809/ https://ncbi.nlm.nih.gov/pubmed/32616532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-233842 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|